ID   AML10
AC   CVCL_UI48
DR   cancercelllines; CVCL_UI48
DR   Cosmic; 1760554
DR   Wikidata; Q93324954
RX   PubMed=22272203;
RX   PubMed=22675565;
CC   Sequence variation: Mutation; HGNC; 12440; TYK2; Simple; p.Arg243Trp (c.727C>T); ClinVar=VCV000890826; Zygosity=Unspecified (PubMed=22675565).
DI   NCIt; C3171; Acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
RX   PubMed=22272203; DOI=10.1155/2012/683065;
RA   Dutour A., Marin V., Pizzitola I., Valsesia-Wittmann S., Lee D.,
RA   Yvon E., Finney H., Lawson A., Brenner M., Biondi A., Biagi E.,
RA   Rousseau R.;
RT   "In vitro and in vivo antitumor effect of anti-CD33 chimeric
RT   receptor-expressing EBV-CTL against CD33 acute myeloid leukemia.";
RL   Adv. Hematol. 2012:683065.1-683065.10(2012).
//
RX   PubMed=22675565; DOI=10.1371/journal.pone.0038463;
RA   Atak Z.K., De Keersmaecker K., Gianfelici V., Geerdens E.,
RA   Vandepoel R., Pauwels D., Porcu M., Lahortiga I., Brys V., Dirks W.G.,
RA   Quentmeier H., Cloos J., Cuppens H., Uyttebroeck A., Vandenberghe P.,
RA   Cools J., Aerts S.;
RT   "High accuracy mutation detection in leukemia on a selected panel of
RT   cancer genes.";
RL   PLoS ONE 7:E38463-E38463(2012).
//